Search

Author/Creator Bernards, Rene

1. A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction. Issue 4 (14th July 2012)

Authors:
Tian, Sun; Simon, Iris; Moreno, Victor; Roepman, Paul; Tabernero, Josep; Snel, Mireille; van't Veer, Laura; Salazar, Ramon; Bernards, Rene; Capella, Gabriel
Journal:
Gut
Issue:
Volume 62:Issue 4(2013)
Page Start:
540
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival. (2nd December 2018)

Authors:
Sobral-Leite, Marcelo; Van de Vijver, Koen; Michaut, Magali; van der Linden, Rianne; Hooijer, Gerrit K.J.; Horlings, Hugo M.; Severson, Tesa M.; Mulligan, Anna Marie; Weerasooriya, Nayana; Sanders, Joyce; Glas, Annuska M; Wehkamp, Diederik; Mittempergher, Lorenza; Kersten, Kelly; Cimino-Mathews, ...
Journal:
Oncoimmunology
Issue:
Volume 7:Number 12(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition. Issue 3 (13th September 2013)

Authors:
Roepman, Paul; Schlicker, Andreas; Tabernero, Josep; Majewski, Ian; Tian, Sun; Moreno, Victor; Snel, Mireille H; Chresta, Christine M; Rosenberg, Robert; Nitsche, Ulrich; Macarulla, Teresa; Capella, Gabriel; Salazar, Ramon; Orphanides, George; Wessels, Lodewyk FA; Bernards, Rene; Simon, Iris M
Journal:
International journal of cancer
Issue:
Volume 134:Issue 3(2014:Feb. 01)
Page Start:
552
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response. Issue 1 (December 2015)

Authors:
Lips, Esther; Michaut, Magali; Hoogstraat, Marlous; Mulder, Lennart; Besselink, Nicolle; Koudijs, Marco; Cuppen, Edwin; Voest, Emile; Bernards, Rene; Nederlof, Petra; Wesseling, Jelle; Rodenhuis, Sjoerd; Wessels, Lodewyk
Journal:
Breast cancer research
Issue:
Volume 17:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer. (29th December 2020)

Authors:
van Brummelen, Emilie M.J.; Huijberts, Sanne; van Herpen, Carla; Desar, Ingrid; Opdam, Frans; van Geel, Robin; Marchetti, Serena; Steeghs, Neeltje; Monkhorst, Kim; Thijssen, Bas; Rosing, Hilde; Huitema, Alwin; Beijnen, Jos; Bernards, Rene; Schellens, Jan
Journal:
Oncologist
Issue:
Volume 26:Number 4(2021)
Page Start:
290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer. (29th December 2020)

Authors:
Brummelen, Emilie M.J.; Huijberts, Sanne; Herpen, Carla; Desar, Ingrid; Opdam, Frans; Geel, Robin; Marchetti, Serena; Steeghs, Neeltje; Monkhorst, Kim; Thijssen, Bas; Rosing, Hilde; Huitema, Alwin; Beijnen, Jos; Bernards, Rene; Schellens, Jan
Journal:
Oncologist
Issue:
Volume 26:Number 4(2021)
Page Start:
290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗